Florida Senate - 2024 SB 672



By Senator Calatayud





38-00604-24 2024672__
1 A bill to be entitled
2 An act relating to intravenous vitamin treatment;
3 providing a short title; creating s. 456.0302, F.S.;
4 defining the terms “health care provider” and
5 “intravenous vitamin treatment”; specifying
6 requirements for health care providers administering
7 intravenous vitamin treatment; requiring the Board of
8 Nursing, the Board of Medicine, and the Board of
9 Osteopathic Medicine to adopt rules establishing
10 procedures to administer intravenous vitamin treatment
11 and emergency protocols; providing for disciplinary
12 action for violations of the act; providing an
13 effective date.
14
15 Be It Enacted by the Legislature of the State of Florida:
16
17 Section 1. This act may be cited as the “Stephanie Balais
18 Act.”
19 Section 2. Section 456.0302, Florida Statutes, is created
20 to read:
21 456.0302 Administering intravenous vitamin treatment.—
22 (1) As used in this section, the term:
23 (a) “Health care provider” means a person licensed under
24 chapter 458, chapter 459, or chapter 464.
25 (b) “Intravenous vitamin treatment” means a procedure in
26 which high concentrations of vitamins and minerals are
27 administered directly into a person’s bloodstream, allowing
28 rapid absorption of higher doses of the vitamins and minerals
29 than if received through food or supplements.
30 (2) A health care provider administering intravenous
31 vitamin treatment shall:
32 (a) Obtain a complete self-screening risk assessment
33 questionnaire from a patient before administering an intravenous
34 vitamin treatment. The health care provider must use a form
35 adopted by rule by the applicable board.
36 (b) Provide a patient with information related to potential
37 side effects and risks of intravenous vitamin treatment and
38 instructions on when to seek medical attention.
39 (c) Provide a patient with a visit summary.
40 (d) Notify a patient’s designated physician that an
41 intravenous vitamin treatment was administered.
42 (e) Have a written plan for the provision of emergency
43 care. A copy of the emergency plan must be kept at the location
44 offering intravenous vitamin treatment. The plan must include
45 all of the following:
46 1. The name and address of the hospital closest to the
47 location at which the intravenous vitamin treatment is being
48 administered.
49 2. Reasons for which an emergency transfer of a patient may
50 be required.
51 3. Medical services to be used in the event of a health
52 emergency.
53 (3) A health care provider may not administer intravenous
54 vitamin treatment to a patient if the provider determines that
55 it is unsafe to administer such treatment based upon the results
56 of the self-screening risk assessment questionnaire or
57 otherwise.
58 (4) The respective boards shall adopt rules establishing
59 procedures to safely administer intravenous vitamin treatment
60 and establish protocols to follow in the event of a health
61 emergency, including, but not limited to, requirements for:
62 (a) Education and training for health care providers
63 authorized to administer intravenous vitamin treatment.
64 (b) Self-screening risk assessments.
65 (c) Information that a health care provider must provide to
66 a patient before administering an intravenous vitamin treatment.
67 (d) Documentation regarding the process of administering
68 intravenous vitamin treatment.
69 (e) Notification that must be provided to a patient’s
70 designated physician if an intravenous vitamin treatment is
71 administered.
72 (f) Evaluation and review of the administration practices
73 used to administer intravenous vitamin treatment.
74 (5) A violation of this section constitutes grounds for
75 disciplinary action under this chapter and chapter 458, chapter
76 459, or chapter 464, as applicable.
77 Section 3. This act shall take effect July 1, 2024.